HEADER TRANSCRIPTION 22-AUG-16 5T1Z TITLE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN Y537S MUTANT IN COMPLEX TITLE 2 WITH ETHOXYTRIPHENYLETHYLENE AND GRIP PEPTIDE CAVEAT 5T1Z ANISOU RECORDS IN THE ABSENCE OF TLS RECORDS C-N BOND IS CAVEAT 2 5T1Z OUTSIDE OF THE ACCEPTED RANGE FOR A LYS 529-A CYS 530 AND B CAVEAT 3 5T1Z GLU 380-B MET 381 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ER,ER-ALPHA,ESTRADIOL RECEPTOR,NUCLEAR RECEPTOR SUBFAMILY 3 COMPND 5 GROUP A MEMBER 1; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: NUCLEAR RECEPTOR COACTIVATOR 2; COMPND 9 CHAIN: C, D; COMPND 10 SYNONYM: NCOA-2,CLASS E BASIC HELIX-LOOP-HELIX PROTEIN 75,BHLHE75, COMPND 11 TRANSCRIPTIONAL INTERMEDIARY FACTOR 2,HTIF2; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ESR1, ESR, NR3A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606 KEYWDS ESTROGEN RECEPTOR, ANGULAR ESTROGEN, BREAST CANCER, AGONIST, KEYWDS 2 ESTROGENIC, APOPTOSIS, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR S.W.FANNING,S.S.RAJAN,P.Y.MAXIMOV,B.H.ABDERRAHMAN,S.SUROJEET, AUTHOR 2 D.J.FERNANDES,P.FAN,R.F.CURPAN,G.L.GREENE,V.C.JORDAN REVDAT 4 04-OCT-23 5T1Z 1 REMARK REVDAT 3 04-JUL-18 5T1Z 1 JRNL REVDAT 2 13-JUN-18 5T1Z 1 JRNL REVDAT 1 30-AUG-17 5T1Z 0 SPRSDE 30-AUG-17 5T1Z 3Q97 JRNL AUTH P.Y.MAXIMOV,B.ABDERRAHMAN,S.W.FANNING,S.SENGUPTA,P.FAN, JRNL AUTH 2 R.F.CURPAN,D.M.Q.RINCON,J.A.GREENLAND,S.S.RAJAN,G.L.GREENE, JRNL AUTH 3 V.C.JORDAN JRNL TITL ENDOXIFEN, 4-HYDROXYTAMOXIFEN AND AN ESTROGENIC DERIVATIVE JRNL TITL 2 MODULATE ESTROGEN RECEPTOR COMPLEX MEDIATED APOPTOSIS IN JRNL TITL 3 BREAST CANCER. JRNL REF MOL. PHARMACOL. V. 94 812 2018 JRNL REFN ESSN 1521-0111 JRNL PMID 29739819 JRNL DOI 10.1124/MOL.117.111385 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.65 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.6 REMARK 3 NUMBER OF REFLECTIONS : 28108 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.186 REMARK 3 R VALUE (WORKING SET) : 0.182 REMARK 3 FREE R VALUE : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.050 REMARK 3 FREE R VALUE TEST SET COUNT : 1419 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 33.6569 - 4.5245 0.99 2903 155 0.1577 0.2131 REMARK 3 2 4.5245 - 3.5925 0.82 2367 133 0.1530 0.2155 REMARK 3 3 3.5925 - 3.1388 0.98 2825 160 0.1855 0.2621 REMARK 3 4 3.1388 - 2.8520 1.00 2881 153 0.1998 0.2684 REMARK 3 5 2.8520 - 2.6477 1.00 2864 153 0.2035 0.2646 REMARK 3 6 2.6477 - 2.4916 1.00 2888 154 0.2017 0.2526 REMARK 3 7 2.4916 - 2.3669 1.00 2847 154 0.1979 0.2685 REMARK 3 8 2.3669 - 2.2639 0.94 2687 152 0.2287 0.3027 REMARK 3 9 2.2639 - 2.1767 0.58 1663 81 0.2670 0.3184 REMARK 3 10 2.1767 - 2.1016 0.96 2764 124 0.2288 0.2987 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.230 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.400 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 4134 REMARK 3 ANGLE : 1.229 5591 REMARK 3 CHIRALITY : 0.041 652 REMARK 3 PLANARITY : 0.005 698 REMARK 3 DIHEDRAL : 14.519 1525 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5T1Z COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-AUG-16. REMARK 100 THE DEPOSITION ID IS D_1000223503. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-JAN-11 REMARK 200 TEMPERATURE (KELVIN) : 77 REMARK 200 PH : 8.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.99 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28624 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.5 REMARK 200 DATA REDUNDANCY : 4.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 2.1800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 2QA6 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.19 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.37 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.15 M KBR, 30% W/V MPEG 2,000, 100 MM REMARK 280 TRIS PH 8.3, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 42.10650 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5550 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20650 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -30.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 462 REMARK 465 SER A 463 REMARK 465 SER A 464 REMARK 465 THR A 465 REMARK 465 LEU A 466 REMARK 465 HIS A 550 REMARK 465 ALA A 551 REMARK 465 PRO A 552 REMARK 465 THR A 553 REMARK 465 SER A 554 REMARK 465 ASP B 332 REMARK 465 PRO B 333 REMARK 465 LEU B 462 REMARK 465 SER B 463 REMARK 465 SER B 464 REMARK 465 THR B 465 REMARK 465 LEU B 549 REMARK 465 HIS B 550 REMARK 465 ALA B 551 REMARK 465 PRO B 552 REMARK 465 THR B 553 REMARK 465 SER B 554 REMARK 465 LYS C 2000 REMARK 465 SER C 2011 REMARK 465 SER C 2012 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 306 CG CD1 CD2 REMARK 470 MET A 437 CG SD CE REMARK 470 LYS A 467 CG CD CE NZ REMARK 470 SER A 468 OG REMARK 470 ARG A 548 CG CD NE CZ NH1 NH2 REMARK 470 LEU B 306 CG CD1 CD2 REMARK 470 GLU B 330 CG CD OE1 OE2 REMARK 470 LEU B 466 CG CD1 CD2 REMARK 470 LYS B 467 CG CD CE NZ REMARK 470 LEU B 469 CG CD1 CD2 REMARK 470 GLU B 470 CG CD OE1 OE2 REMARK 470 LYS B 472 CG CD CE NZ REMARK 470 TYR B 526 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS B 529 CG CD CE NZ REMARK 470 LYS B 531 CG CD CE NZ REMARK 470 ARG B 548 CG CD NE CZ NH1 NH2 REMARK 470 ASP C2010 CG OD1 OD2 REMARK 470 LYS D2000 CG CD CE NZ REMARK 470 SER D2012 OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASP B 473 NH1 ARG B 477 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS B 531 90.84 -60.87 REMARK 500 ASN B 532 86.15 -66.05 REMARK 500 VAL B 533 -82.44 -108.14 REMARK 500 HIS D2001 -9.79 -150.74 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue Q97 A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue Q97 B 1000 DBREF 5T1Z A 305 554 UNP P03372 ESR1_HUMAN 305 554 DBREF 5T1Z B 305 554 UNP P03372 ESR1_HUMAN 305 554 DBREF 5T1Z C 2000 2012 UNP Q15596 NCOA2_HUMAN 686 698 DBREF 5T1Z D 2000 2012 UNP Q15596 NCOA2_HUMAN 686 698 SEQADV 5T1Z MET A 381 UNP P03372 CYS 381 CONFLICT SEQADV 5T1Z SER A 537 UNP P03372 TYR 537 ENGINEERED MUTATION SEQADV 5T1Z MET B 381 UNP P03372 CYS 381 CONFLICT SEQADV 5T1Z SER B 537 UNP P03372 TYR 537 ENGINEERED MUTATION SEQRES 1 A 250 SER LEU ALA LEU SER LEU THR ALA ASP GLN MET VAL SER SEQRES 2 A 250 ALA LEU LEU ASP ALA GLU PRO PRO ILE LEU TYR SER GLU SEQRES 3 A 250 TYR ASP PRO THR ARG PRO PHE SER GLU ALA SER MET MET SEQRES 4 A 250 GLY LEU LEU THR ASN LEU ALA ASP ARG GLU LEU VAL HIS SEQRES 5 A 250 MET ILE ASN TRP ALA LYS ARG VAL PRO GLY PHE VAL ASP SEQRES 6 A 250 LEU THR LEU HIS ASP GLN VAL HIS LEU LEU GLU MET ALA SEQRES 7 A 250 TRP LEU GLU ILE LEU MET ILE GLY LEU VAL TRP ARG SER SEQRES 8 A 250 MET GLU HIS PRO GLY LYS LEU LEU PHE ALA PRO ASN LEU SEQRES 9 A 250 LEU LEU ASP ARG ASN GLN GLY LYS CYS VAL GLU GLY MET SEQRES 10 A 250 VAL GLU ILE PHE ASP MET LEU LEU ALA THR SER SER ARG SEQRES 11 A 250 PHE ARG MET MET ASN LEU GLN GLY GLU GLU PHE VAL CYS SEQRES 12 A 250 LEU LYS SER ILE ILE LEU LEU ASN SER GLY VAL TYR THR SEQRES 13 A 250 PHE LEU SER SER THR LEU LYS SER LEU GLU GLU LYS ASP SEQRES 14 A 250 HIS ILE HIS ARG VAL LEU ASP LYS ILE THR ASP THR LEU SEQRES 15 A 250 ILE HIS LEU MET ALA LYS ALA GLY LEU THR LEU GLN GLN SEQRES 16 A 250 GLN HIS GLN ARG LEU ALA GLN LEU LEU LEU ILE LEU SER SEQRES 17 A 250 HIS ILE ARG HIS MET SER ASN LYS GLY MET GLU HIS LEU SEQRES 18 A 250 TYR SER MET LYS CYS LYS ASN VAL VAL PRO LEU SER ASP SEQRES 19 A 250 LEU LEU LEU GLU MET LEU ASP ALA HIS ARG LEU HIS ALA SEQRES 20 A 250 PRO THR SER SEQRES 1 B 250 SER LEU ALA LEU SER LEU THR ALA ASP GLN MET VAL SER SEQRES 2 B 250 ALA LEU LEU ASP ALA GLU PRO PRO ILE LEU TYR SER GLU SEQRES 3 B 250 TYR ASP PRO THR ARG PRO PHE SER GLU ALA SER MET MET SEQRES 4 B 250 GLY LEU LEU THR ASN LEU ALA ASP ARG GLU LEU VAL HIS SEQRES 5 B 250 MET ILE ASN TRP ALA LYS ARG VAL PRO GLY PHE VAL ASP SEQRES 6 B 250 LEU THR LEU HIS ASP GLN VAL HIS LEU LEU GLU MET ALA SEQRES 7 B 250 TRP LEU GLU ILE LEU MET ILE GLY LEU VAL TRP ARG SER SEQRES 8 B 250 MET GLU HIS PRO GLY LYS LEU LEU PHE ALA PRO ASN LEU SEQRES 9 B 250 LEU LEU ASP ARG ASN GLN GLY LYS CYS VAL GLU GLY MET SEQRES 10 B 250 VAL GLU ILE PHE ASP MET LEU LEU ALA THR SER SER ARG SEQRES 11 B 250 PHE ARG MET MET ASN LEU GLN GLY GLU GLU PHE VAL CYS SEQRES 12 B 250 LEU LYS SER ILE ILE LEU LEU ASN SER GLY VAL TYR THR SEQRES 13 B 250 PHE LEU SER SER THR LEU LYS SER LEU GLU GLU LYS ASP SEQRES 14 B 250 HIS ILE HIS ARG VAL LEU ASP LYS ILE THR ASP THR LEU SEQRES 15 B 250 ILE HIS LEU MET ALA LYS ALA GLY LEU THR LEU GLN GLN SEQRES 16 B 250 GLN HIS GLN ARG LEU ALA GLN LEU LEU LEU ILE LEU SER SEQRES 17 B 250 HIS ILE ARG HIS MET SER ASN LYS GLY MET GLU HIS LEU SEQRES 18 B 250 TYR SER MET LYS CYS LYS ASN VAL VAL PRO LEU SER ASP SEQRES 19 B 250 LEU LEU LEU GLU MET LEU ASP ALA HIS ARG LEU HIS ALA SEQRES 20 B 250 PRO THR SER SEQRES 1 C 13 LYS HIS LYS ILE LEU HIS ARG LEU LEU GLN ASP SER SER SEQRES 1 D 13 LYS HIS LYS ILE LEU HIS ARG LEU LEU GLN ASP SER SER HET Q97 A 601 27 HET Q97 B1000 27 HETNAM Q97 4,4'-[(1Z)-1-(4-ETHOXYPHENYL)BUT-1-ENE-1,2- HETNAM 2 Q97 DIYL]DIPHENOL FORMUL 5 Q97 2(C24 H24 O3) FORMUL 7 HOH *143(H2 O) HELIX 1 AA1 SER A 305 LEU A 310 5 6 HELIX 2 AA2 THR A 311 ALA A 322 1 12 HELIX 3 AA3 SER A 338 ARG A 363 1 26 HELIX 4 AA4 THR A 371 MET A 396 1 26 HELIX 5 AA5 ARG A 412 LYS A 416 1 5 HELIX 6 AA6 GLY A 420 ASN A 439 1 20 HELIX 7 AA7 GLN A 441 SER A 456 1 16 HELIX 8 AA8 GLY A 457 PHE A 461 5 5 HELIX 9 AA9 SER A 468 ALA A 493 1 26 HELIX 10 AB1 THR A 496 LYS A 529 1 34 HELIX 11 AB2 SER A 537 ALA A 546 1 10 HELIX 12 AB3 LEU B 306 LEU B 310 5 5 HELIX 13 AB4 THR B 311 GLU B 323 1 13 HELIX 14 AB5 SER B 338 LYS B 362 1 25 HELIX 15 AB6 GLY B 366 LEU B 370 5 5 HELIX 16 AB7 THR B 371 GLU B 380 1 10 HELIX 17 AB8 ALA B 382 MET B 396 1 15 HELIX 18 AB9 ASN B 413 VAL B 418 5 6 HELIX 19 AC1 GLY B 420 MET B 438 1 19 HELIX 20 AC2 GLN B 441 SER B 456 1 16 HELIX 21 AC3 GLY B 457 PHE B 461 5 5 HELIX 22 AC4 LEU B 466 LYS B 467 5 2 HELIX 23 AC5 SER B 468 ALA B 493 1 26 HELIX 24 AC6 THR B 496 TYR B 526 1 31 HELIX 25 AC7 SER B 537 ALA B 546 1 10 HELIX 26 AC8 LYS C 2002 LEU C 2008 1 7 HELIX 27 AC9 LYS D 2002 LEU D 2008 1 7 SHEET 1 AA1 2 LYS A 401 ALA A 405 0 SHEET 2 AA1 2 LEU A 408 ASP A 411 -1 O LEU A 410 N LEU A 402 SHEET 1 AA2 2 LYS B 401 ALA B 405 0 SHEET 2 AA2 2 LEU B 408 ASP B 411 -1 O LEU B 410 N LEU B 402 SITE 1 AC1 14 THR A 347 ALA A 350 GLU A 353 TRP A 383 SITE 2 AC1 14 LEU A 387 ARG A 394 PHE A 404 MET A 421 SITE 3 AC1 14 GLY A 521 HIS A 524 LEU A 525 MET A 528 SITE 4 AC1 14 LEU A 540 HOH A 739 SITE 1 AC2 13 THR B 347 ALA B 350 GLU B 353 TRP B 383 SITE 2 AC2 13 LEU B 387 ARG B 394 PHE B 404 ILE B 424 SITE 3 AC2 13 LEU B 428 GLY B 521 HIS B 524 LEU B 540 SITE 4 AC2 13 HOH B1112 CRYST1 56.091 84.213 58.967 90.00 108.28 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017828 0.000000 0.005889 0.00000 SCALE2 0.000000 0.011875 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017860 0.00000